source
- Induced pluripotent stem cells gain momentum as new methods and clinical successes drive drug developmentInduced pluripotent stem cells (iPSCs) are moving from a research curiosity to a practical tool in drug development. After years of steady progress, recent advances are bringing iPSCs into the spot…
- City Therapeutics raises $200 million in IPO, becoming 26th biotech listing of 2026City Therapeutics announced that it has completed a $200 million initial public offering, making it the 26th biotech to go public in 2026. The company, based in Kendall Square, will begin trading…